Breaking News, Collaborations & Alliances

Abzena, BioXpress Therapeutics Enter Biosimilar Tie-up

Partnership to support the development and manufacture of biosimilars for global customers.

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Abzena, a provider of solutions for biologics and bioconjugates, and BioXpress Therapeutics, a developer of monoclonal antibody (mAb) biosimilar therapeutics, have partnered to support biosimilar development for third party customers. The partnership creates an integrated solution between two service providers with expertise in biosimilar development and GMP manufacture.   The partnership will ensure biosimilar drug developers benefit from an integrated approach to biosimilars spanning the range...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters